Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 41 min ago
Peer-reviewedCC BY-NC-SASaudi Journal of Kidney Diseases and Transplantation

Peritoneal dialysis in patients with end-stage renal disease, chronic liver disease and ascites: A prospective observational study

Abstract

Objectives: Patients with chronic liver disease (CLD) complicated by ascites may develop end-stage renal disease (ESRD), making selection of renal replacement therapy challenging. This study described the feasibility and clinical outcomes of peritoneal dialysis (PD) in selected patients with ESRD, CLD, and ascites. Patients and Methods: This prospective observational study included 51 selected patients with ESRD, CLD, and ascites and 55 patients with ESRD without CLD who underwent PD at a tertiary university hospital in Saudi Arabia. All underwent percutaneous insertion of a three-cuff PD catheter and received automated peritoneal dialysis (APD). Clinical outcomes recorded during observed follow-up are presented descriptively. Results: Percutaneous catheter insertion was successful in all patients without bowel perforation, catheter migration, or major hemorrhage. Thirteen peritonitis episodes were recorded in the CLD group and 12 in the non-CLD group. The overall peritonitis rate was 0.10 episodes per patient-year; group-specific rates were 0.11 and 0.09 episodes per patient-year, respectively. None required catheter removal. A transient serum albumin decline of at least 0.5 g/dL was recorded in 5 and 4 patients, respectively. Early dialysate leakage occurred in 7/51 and 3/55 patients and was managed by temporary reduction of fill volume. During observed follow-up, 12/51 patients with CLD and 9/55 patients without CLD died. Conclusions: Peritoneal dialysis was feasible in this selected cohort of patients with ESRD, chronic liver disease, and ascites. The observed adequacy values, complication counts, and crude mortality are reported descriptively. The findings should not be interpreted as establishing safety, effectiveness, equivalence, or superiority.

Related

  1. Predicting cardiovascular disease in peritoneal dialysis patients using glycated proteomics and machine learning: A prospective multicentre study
    Ji Ji, Zhaoying Nie, Na Jiang +13
    Clinical and Translational MedicinePeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  2. Association of 24 h Pulse Pressure Derived from Ambulatory Blood Pressure Monitoring with All-Cause and Cardiovascular Mortality in Patients Undergoing Peritoneal Dialysis: A Prospective Cohort Study
    Jing Yu, Rui Yang, Xi Xia +8
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Regional Collaboration with Home Care Physicians is Associated with a Lower Proportion of In-hospital Deaths in Peritoneal Dialysis patients: A Single-center Retrospective Observational Study
    Hideaki Oka, Shunsuke Yamada, Kana Ota +4
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  4. Association between handgrip strength and risk of all-cause mortality in peritoneal dialysis patients: a prospective cohort study
    Beixia Zhu, Lailiang Wang, Youjun Xu +4
    Scientific ReportsPeer-reviewedCC BYFull text1 citedGeneral medicineDOAJ
  5. Clinical characteristics and preliminary discriminatory value of low triiodothyronine syndrome in patients with peritoneal dialysis-associated peritonitis : A cross-sectional study
    Jiaxin Liu, Liqiang Lv, Junyuan Xiao +3
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{alhwiesh2026peritoneal,
  title = {{Peritoneal dialysis in patients with end-stage renal disease, chronic liver disease and ascites: A prospective observational study}},
  author = {Abdullah Al-Hwiesh and Ibrahiem Saeed Abdul-Rahman and Mohammed Ahmed Nasreldin and Moaz Abdulgalil and Khadija M. Alshehabi and Nadia Al-Audah and Abdullah D. Alotibi and Suzan Aloudah},
  journal = {Saudi Journal of Kidney Diseases and Transplantation},
  year = {2026},
  month = jul,
  doi = {10.4103/sjkdt.sjkdt_205_25},
  url = {https://doi.org/10.4103/sjkdt.sjkdt_205_25},
  note = {CC BY-NC-SA},
}
RIS
TY  - JOUR
TI  - Peritoneal dialysis in patients with end-stage renal disease, chronic liver disease and ascites: A prospective observational study
AU  - Abdullah Al-Hwiesh
AU  - Ibrahiem Saeed Abdul-Rahman
AU  - Mohammed Ahmed Nasreldin
AU  - Moaz Abdulgalil
AU  - Khadija M. Alshehabi
AU  - Nadia Al-Audah
AU  - Abdullah D. Alotibi
AU  - Suzan Aloudah
PY  - 2026
DA  - 2026/07/01
JO  - Saudi Journal of Kidney Diseases and Transplantation
DO  - 10.4103/sjkdt.sjkdt_205_25
UR  - https://doi.org/10.4103/sjkdt.sjkdt_205_25
AB  - Objectives: Patients with chronic liver disease (CLD) complicated by ascites may develop end-stage renal disease (ESRD), making selection of renal replacement therapy challenging. This study described the feasibility and clinical outcomes of peritoneal dialysis (PD) in selected patients with ESRD, CLD, and ascites. Patients and Methods: This prospective observational study included 51 selected patients with ESRD, CLD, and ascites and 55 patients with ESRD without CLD who underwent PD at a tertiary university hospital in Saudi Arabia. All underwent percutaneous insertion of a three-cuff PD catheter and received automated peritoneal dialysis (APD). Clinical outcomes recorded during observed follow-up are presented descriptively. Results: Percutaneous catheter insertion was successful in all patients without bowel perforation, catheter migration, or major hemorrhage. Thirteen peritonitis episodes were recorded in the CLD group and 12 in the non-CLD group. The overall peritonitis rate was 0.10 episodes per patient-year; group-specific rates were 0.11 and 0.09 episodes per patient-year, respectively. None required catheter removal. A transient serum albumin decline of at least 0.5 g/dL was recorded in 5 and 4 patients, respectively. Early dialysate leakage occurred in 7/51 and 3/55 patients and was managed by temporary reduction of fill volume. During observed follow-up, 12/51 patients with CLD and 9/55 patients without CLD died. Conclusions: Peritoneal dialysis was feasible in this selected cohort of patients with ESRD, chronic liver disease, and ascites. The observed adequacy values, complication counts, and crude mortality are reported descriptively. The findings should not be interpreted as establishing safety, effectiveness, equivalence, or superiority.
SN  - 1319-2442
SN  - 2320-3838
ER  -